Larvol Delta - Safety-and-Efficacy-of-CRISPRCas9-mRNA-Instantaneous-Gene-Editing-Therapy-to-Treat-Refractory-Viral-Keratitis

BD111 - BDgene

http://clinicaltrials.gov/ct2/show/NCT04560790

Aug 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev